A carregar...
Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer
Cabazitaxel (CBZ) is approved for docetaxel‐resistant castration‐resistant prostate cancer (CRPC). However, efficacy of CBZ for CRPC is limited and there are no effective treatments for CBZ‐resistant CRPC. In order to investigate the CBZ‐resistant mechanism, the establishment of a CBZ‐resistant cell...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125448/ https://ncbi.nlm.nih.gov/pubmed/29989268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13729 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|